First-in-human feasibility study of a portable low-field pulsed-gradient-free MR device in acute stroke
We conducted the first-in-human evaluation of a novel portable low-field 0.1 T pulsed-gradient-free magnetic resonance (MR) device (~ 100 kg) that acquires regional MR biomarkers for bedside stroke assessment. We aimed to evaluate its safety, tolerability and feasibility in acute stroke. This single-centre non-randomised observational cohort study prospectively recruited healthy controls and consecutive stroke patients within 72-h of hospital presentation. Participants underwent conventional 1.5–3 T MRI and two consecutive device scans (DWI, T2). The primary outcomes were feasibility with the proportion of scans where an interpretable signal-to-noise ratio (SNR) was obtained, safety, and tolerability via survey. Forty of forty-nine participants with acute stroke (34 ischemic and 6 hemorrhagic) had successful scans; median age 71 (years[IQR 58.5–76.5]); median NIHSS 4.5 [IQR 2.0–12.0]) and 20 healthy controls were enrolled. No device-related safety concerns were identified, and the scanner was generally well tolerated. SNR ≥ 3 for algorithm-based analysis were obtained in 36/40 (90.0%) stroke participants and 12/40 (30.0%) achieved the higher threshold for heatmap visualisation (SNR ≥ 12). This first-in-human study demonstrates the safety, tolerability, and technical feasibility of operating the device within an inpatient stroke workflow and generate interpretable MR-derived signals in most patients. These findings justify larger prospective studies to evaluate diagnostic performance and clinical implementation.
Authors
- Sergei I. Obruchkov (ORCID: https://orcid.org/0000-0003-2499-0195)
- James L. Barker (ORCID: https://orcid.org/0000-0001-7579-0535)
- Javier M. Romero (ORCID: https://orcid.org/0000-0001-5749-3000)
- Leonid P. Churilov (ORCID: https://orcid.org/0000-0002-9807-6606)
- David S. Liebeskind (ORCID: https://orcid.org/0000-0002-5109-8736)
- Samantha Rivet (ORCID: https://orcid.org/0000-0001-6099-237X)
- Geoffrey Alan Donnan (ORCID: https://orcid.org/0000-0001-6324-3403)
- Stephen M. Davis (ORCID: https://orcid.org/0000-0003-0962-2300)
- Paul D. Teal (ORCID: https://orcid.org/0000-0002-6111-6280)
- Oshi Swarup (ORCID: https://orcid.org/0000-0003-4610-1803)
- Dion Thomas
- Yu‐Chieh Tzeng (ORCID: https://orcid.org/0000-0001-8951-5825)
- Bruce C.V. Campbell (ORCID: https://orcid.org/0000-0003-3632-9433)
- Mark William Parsons (ORCID: https://orcid.org/0000-0001-8874-2487)
- J I Goldstein (ORCID: https://orcid.org/0000-0002-6406-1828)
- Amy McDonald
- Laura Mulligan
- Sean Pierce
- Osama O. Zaidat
- Peter Anderyas (ORCID: https://orcid.org/0009-0004-5592-9439)
- Flynn Stilwill
- Tyson Moed
- Anne W. Alexandrov
- Andrei V. Alexandrov
- Kern Cowell
- Gerard Loquet
Institutions
- University of Southern California (US)
- The University of Sydney (AU)
- Mercy St. Vincent Medical Center (US)
- The Royal Melbourne Hospital (AU)
- Harvard University (US)
- University of Tennessee Health Science Center (US)
- The University of Melbourne (AU)
- Westmead Hospital (AU)
- Massachusetts General Hospital (US)
- University of Arizona College of Medicine- Phoenix (US)
Publication Details
- Journal
- Scientific Reports
- Published
- 2026-11-18
- DOI
- https://doi.org/10.1038/s41598-026-80754-0
- Primary Topic
- Advanced MRI Techniques and Applications
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Australian Government
- Medical Research Future Fund